Urgent Care Apps Market By Product (Emergency Care Triage Apps, In-hospital Communication Apps, Post-hospital Apps), By Clinical area (Trauma, Stroke, Cardiac Conditions, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

Description

List of Tables

The Urgent Care Apps Market valued for $1.4 billion in 2022 and is estimated to reach $23.5 billion by 2032, exhibiting a CAGR of 32.5% from 2023 to 2032. Urgent care apps are beneficial in handling medical conditions that need an immediate response. They function as a pathway for medical conditions that require instant actions.

Moreover, they offer low-cost options for health conditions, such as cardiac diseases and pregnancy. The majority of healthcare organizations make the best use of urgent care apps for delivering the best services to patients, and arranging the appointment at the earliest, to provide the best care to patients. These apps shift consumers from traditional treatment to digital devices. The increase in severe conditions such as trauma and other diseases has improved the use of urgent care apps. The benefits offered by these apps for the medicinal dosage and check-ups contribute to the growth of the healthcare sector. These apps are useful, especially for older people who need immediate help during emergencies.

The growth of the urgent care apps market is driven by surge in incidence of chronic diseases, increase in availability & affordability of apps, and rise in number of advanced product launches. Moreover, large healthcare IT firms all over the world increasingly focus on acquiring companies that provide solutions for the tests, which is expected to notably contribute toward the market growth. For instance, in March 2022, ICV Partners, LLC, a leading investment firm focused on lower middle market companies in business services, announced the acquisition of Urgent Care Group (UCG) and its combination with portfolio company Total Access Urgent Care (TAUC).

Furthermore, the global urgent care apps market growth is largely driven by factors such as significant applications of urgent care apps in digital world, various initiatives & funding from government & private bodies for large-scale urgent care apps projects, rise in adoption of the 3G, 4G, and 5G networks and the increase in penetration of the smartphones among the population. Prominent players in the global urgent care apps market have opted various strategies such as product launches, acquisition, and investments in R&D for advancement in urgent care apps to strengthen their position in the market and sustain the competitive environment.

An alarming increase in prevalence of diseases across the globe is one of the key factors that drive the growth of the market. However, the poor internet connectivity in developing countries restricts market growth. Conversely, the increase in population of smart phone users and the awareness about medication management apps, especially among patients in emerging nations, are expected to provide lucrative opportunities for the growth of the market in the near future. Extensive R&D activities in the field of healthcare IT along with significant improvement in healthcare infrastructure are anticipated to open new avenues for the expansion of the market.

The urgent care apps market is segmented on the basis of product, clinical area, and region. On the basis of product, the market is categorized into emergency care triage apps, in-hospital communication apps and post-hospital apps. On the basis of clinical area, the market is classified into trauma, stroke, cardiac conditions, others. On the basis of region, the market is studied across North America (the U.S., Mayada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major companies profiled in the report include AlayaCare, Allm Inc, Argusoft, Brave Care Inc, Epic Systems Corporation, Johnson & Johnson, Stryker Corporation, Teladoc Health, Inc., TigerConnect, and Zocdoc, Inc.

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the urgent care apps market analysis from 2022 to 2032 to identify the prevailing urgent care apps market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the urgent care apps market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global urgent care apps market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Clinical area

Trauma
Stroke
Cardiac Conditions
Others

By Product

Emergency Care Triage Apps
In-hospital Communication Apps
Post-hospital Apps

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Key Market Players:

AlayaCare
Allm Inc.
Argusoft
Brave Care, Inc
Epic Systems Corporation
Johnson & Johnson
Stryker Corporation
Teladoc Health, Inc.
TigerConnect
Zocdoc, Inc.

Product Code: A04696

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
3.3. Porter's five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
3.4. Market dynamics
- 3.4.1. Drivers
  - 3.4.1.1. Increase in use of smartphones
  - 3.4.1.2. Growth in penetration of 4G and 5G networks
  - 3.4.1.3. Rise in focus on patient-centric healthcare delivery

3.4.2. Restraints
- 3.4.2.1. The poor internet connectivity in developing countries

3.4.3. Opportunities
- 3.4.3.1. Surge in awareness about telehealth apps

3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: URGENT CARE APPS MARKET, BY PRODUCT

4.1. Overview
- 4.1.1. Market size and forecast
4.2. Emergency Care Triage Apps
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
4.3. In-hospital Communication Apps
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
4.4. Post-hospital Apps
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country

CHAPTER 5: URGENT CARE APPS MARKET, BY CLINICAL AREA

5.1. Overview
- 5.1.1. Market size and forecast
5.2. Trauma
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
5.3. Stroke
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
5.4. Cardiac Conditions
- 5.4.1. Key market trends, growth factors and opportunities
- 5.4.2. Market size and forecast, by region
- 5.4.3. Market share analysis by country
5.5. Others
- 5.5.1. Key market trends, growth factors and opportunities
- 5.5.2. Market size and forecast, by region
- 5.5.3. Market share analysis by country

CHAPTER 6: URGENT CARE APPS MARKET, BY REGION

6.1. Overview
- 6.1.1. Market size and forecast By Region
6.2. North America
- 6.2.1. Key trends and opportunities
- 6.2.2. Market size and forecast, by Product
- 6.2.3. Market size and forecast, by Clinical area
- 6.2.4. Market size and forecast, by country
  - 6.2.4.1. U.S.
  - 6.2.4.1.1. Key market trends, growth factors and opportunities
  - 6.2.4.1.2. Market size and forecast, by Product
  - 6.2.4.1.3. Market size and forecast, by Clinical area
  - 6.2.4.2. Canada
  - 6.2.4.2.1. Key market trends, growth factors and opportunities
  - 6.2.4.2.2. Market size and forecast, by Product
  - 6.2.4.2.3. Market size and forecast, by Clinical area
  - 6.2.4.3. Mexico
  - 6.2.4.3.1. Key market trends, growth factors and opportunities
  - 6.2.4.3.2. Market size and forecast, by Product
  - 6.2.4.3.3. Market size and forecast, by Clinical area
6.3. Europe
- 6.3.1. Key trends and opportunities
- 6.3.2. Market size and forecast, by Product
- 6.3.3. Market size and forecast, by Clinical area
- 6.3.4. Market size and forecast, by country
  - 6.3.4.1. Germany
  - 6.3.4.1.1. Key market trends, growth factors and opportunities
  - 6.3.4.1.2. Market size and forecast, by Product
  - 6.3.4.1.3. Market size and forecast, by Clinical area
  - 6.3.4.2. France
  - 6.3.4.2.1. Key market trends, growth factors and opportunities
  - 6.3.4.2.2. Market size and forecast, by Product
  - 6.3.4.2.3. Market size and forecast, by Clinical area
  - 6.3.4.3. UK
  - 6.3.4.3.1. Key market trends, growth factors and opportunities
  - 6.3.4.3.2. Market size and forecast, by Product
  - 6.3.4.3.3. Market size and forecast, by Clinical area
  - 6.3.4.4. Italy
  - 6.3.4.4.1. Key market trends, growth factors and opportunities
  - 6.3.4.4.2. Market size and forecast, by Product
  - 6.3.4.4.3. Market size and forecast, by Clinical area
  - 6.3.4.5. Spain
  - 6.3.4.5.1. Key market trends, growth factors and opportunities
  - 6.3.4.5.2. Market size and forecast, by Product
  - 6.3.4.5.3. Market size and forecast, by Clinical area
  - 6.3.4.6. Rest of Europe
  - 6.3.4.6.1. Key market trends, growth factors and opportunities
  - 6.3.4.6.2. Market size and forecast, by Product
  - 6.3.4.6.3. Market size and forecast, by Clinical area
6.4. Asia-Pacific
- 6.4.1. Key trends and opportunities
- 6.4.2. Market size and forecast, by Product
- 6.4.3. Market size and forecast, by Clinical area
- 6.4.4. Market size and forecast, by country
  - 6.4.4.1. China
  - 6.4.4.1.1. Key market trends, growth factors and opportunities
  - 6.4.4.1.2. Market size and forecast, by Product
  - 6.4.4.1.3. Market size and forecast, by Clinical area
  - 6.4.4.2. Japan
  - 6.4.4.2.1. Key market trends, growth factors and opportunities
  - 6.4.4.2.2. Market size and forecast, by Product
  - 6.4.4.2.3. Market size and forecast, by Clinical area
  - 6.4.4.3. India
  - 6.4.4.3.1. Key market trends, growth factors and opportunities
  - 6.4.4.3.2. Market size and forecast, by Product
  - 6.4.4.3.3. Market size and forecast, by Clinical area
  - 6.4.4.4. Australia
  - 6.4.4.4.1. Key market trends, growth factors and opportunities
  - 6.4.4.4.2. Market size and forecast, by Product
  - 6.4.4.4.3. Market size and forecast, by Clinical area
  - 6.4.4.5. South Korea
  - 6.4.4.5.1. Key market trends, growth factors and opportunities
  - 6.4.4.5.2. Market size and forecast, by Product
  - 6.4.4.5.3. Market size and forecast, by Clinical area
  - 6.4.4.6. Rest of Asia-Pacific
  - 6.4.4.6.1. Key market trends, growth factors and opportunities
  - 6.4.4.6.2. Market size and forecast, by Product
  - 6.4.4.6.3. Market size and forecast, by Clinical area
6.5. LAMEA
- 6.5.1. Key trends and opportunities
- 6.5.2. Market size and forecast, by Product
- 6.5.3. Market size and forecast, by Clinical area
- 6.5.4. Market size and forecast, by country
  - 6.5.4.1. Brazil
  - 6.5.4.1.1. Key market trends, growth factors and opportunities
  - 6.5.4.1.2. Market size and forecast, by Product
  - 6.5.4.1.3. Market size and forecast, by Clinical area
  - 6.5.4.2. Saudi Arabia
  - 6.5.4.2.1. Key market trends, growth factors and opportunities
  - 6.5.4.2.2. Market size and forecast, by Product
  - 6.5.4.2.3. Market size and forecast, by Clinical area
  - 6.5.4.3. South Africa
  - 6.5.4.3.1. Key market trends, growth factors and opportunities
  - 6.5.4.3.2. Market size and forecast, by Product
  - 6.5.4.3.3. Market size and forecast, by Clinical area
  - 6.5.4.4. Rest of LAMEA
  - 6.5.4.4.1. Key market trends, growth factors and opportunities
  - 6.5.4.4.2. Market size and forecast, by Product
  - 6.5.4.4.3. Market size and forecast, by Clinical area

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top winning strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top player positioning, 2022

CHAPTER 8: COMPANY PROFILES

8.1. Allm Inc.
- 8.1.1. Company overview
- 8.1.2. Key Executives
- 8.1.3. Company snapshot
- 8.1.4. Operating business segments
- 8.1.5. Product portfolio
8.2. Stryker Corporation
- 8.2.1. Company overview
- 8.2.2. Key Executives
- 8.2.3. Company snapshot
- 8.2.4. Operating business segments
- 8.2.5. Product portfolio
- 8.2.6. Business performance
- 8.2.7. Key strategic moves and developments
8.3. Johnson & Johnson
- 8.3.1. Company overview
- 8.3.2. Key Executives
- 8.3.3. Company snapshot
- 8.3.4. Operating business segments
- 8.3.5. Product portfolio
- 8.3.6. Business performance
8.4. AlayaCare
- 8.4.1. Company overview
- 8.4.2. Key Executives
- 8.4.3. Company snapshot
- 8.4.4. Operating business segments
- 8.4.5. Product portfolio
- 8.4.6. Key strategic moves and developments
8.5. TigerConnect
- 8.5.1. Company overview
- 8.5.2. Key Executives
- 8.5.3. Company snapshot
- 8.5.4. Operating business segments
- 8.5.5. Product portfolio
- 8.5.6. Key strategic moves and developments
8.6. Teladoc Health, Inc.
- 8.6.1. Company overview
- 8.6.2. Key Executives
- 8.6.3. Company snapshot
- 8.6.4. Operating business segments
- 8.6.5. Product portfolio
- 8.6.6. Business performance
- 8.6.7. Key strategic moves and developments
8.7. Argusoft
- 8.7.1. Company overview
- 8.7.2. Key Executives
- 8.7.3. Company snapshot
- 8.7.4. Operating business segments
- 8.7.5. Product portfolio
8.8. Zocdoc, Inc.
- 8.8.1. Company overview
- 8.8.2. Key Executives
- 8.8.3. Company snapshot
- 8.8.4. Operating business segments
- 8.8.5. Product portfolio
8.9. Brave Care, Inc
- 8.9.1. Company overview
- 8.9.2. Key Executives
- 8.9.3. Company snapshot
- 8.9.4. Operating business segments
- 8.9.5. Product portfolio
8.10. Epic Systems Corporation
- 8.10.1. Company overview
- 8.10.2. Key Executives
- 8.10.3. Company snapshot
- 8.10.4. Operating business segments
- 8.10.5. Product portfolio